Business Description
Valneva SE
ISIN : US92025Y1038
Share Class Description:
VALN: ADRCompare
Compare
Traded in other countries / regions
VLA.FranceVALN.USAAYJ.GermanyVLA.Austria0OB3.UK IPO Date
2021-05-06Description
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.6 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.63 | |||||
| Debt-to-EBITDA | -2.77 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.68 | |||||
| Beneish M-Score | 0.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EBITDA Growth Rate | 5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year Book Growth Rate | 2.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | -6.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.14 | |||||
| 9-Day RSI | 50.54 | |||||
| 14-Day RSI | 51.6 | |||||
| 6-1 Month Momentum % | -25.7 | |||||
| 12-1 Month Momentum % | -25.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.65 | |||||
| Quick Ratio | 1.37 | |||||
| Cash Ratio | 0.79 | |||||
| Days Inventory | 137.44 | |||||
| Days Sales Outstanding | 81.02 | |||||
| Days Payable | 165.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.2 | |||||
| Shareholder Yield % | -5.22 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.37 | |||||
| Operating Margin % | -53.42 | |||||
| Net Margin % | -65.99 | |||||
| FCF Margin % | -141.23 | |||||
| ROE % | -56.28 | |||||
| ROA % | -18.55 | |||||
| ROIC % | -23.3 | |||||
| ROC (Joel Greenblatt) % | -46.73 | |||||
| ROCE % | -23.89 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.25 | |||||
| PB Ratio | 3.75 | |||||
| Price-to-Tangible-Book | 4.65 | |||||
| EV-to-EBIT | -7.59 | |||||
| EV-to-EBITDA | -7.59 | |||||
| EV-to-Revenue | 3.71 | |||||
| EV-to-Forward-Revenue | 3.29 | |||||
| EV-to-FCF | -2.75 | |||||
| Price-to-Median-PS-Value | 1.11 | |||||
| Earnings Yield (Greenblatt) % | -13.18 | |||||
| FCF Yield % | -44.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VALN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Valneva SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 165.789 | ||
| EPS (TTM) ($) | -1.574 | ||
| Beta | 0 | ||
| Volatility % | 52.69 | ||
| 14-Day RSI | 51.6 | ||
| 14-Day ATR ($) | 0.415436 | ||
| 20-Day SMA ($) | 8.07644 | ||
| 12-1 Month Momentum % | -25.4 | ||
| 52-Week Range ($) | 6.58 - 17.05 | ||
| Shares Outstanding (Mil) | 69.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Valneva SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Valneva SE Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Valneva SE Frequently Asked Questions
What is Valneva SE(VALN)'s stock price today?
The current price of VALN is $7.58. The 52 week high of VALN is $17.05 and 52 week low is $6.58.
When is next earnings date of Valneva SE(VALN)?
The next earnings date of Valneva SE(VALN) is 2024-05-07.
Does Valneva SE(VALN) pay dividends? If so, how much?
Valneva SE(VALN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers